期刊文献+

成份输血对食管癌、直肠癌病人术后T淋巴细胞亚群及自然杀伤细胞的影响 被引量:4

Effects of component blood transfusion on postoperative changes in T- lymphocyte subsets and NK cell in patients with esophagus or rectum cancer
原文传递
导出
摘要 目的 探讨成份输血对食管癌、直肠癌病人术后T淋巴细胞亚群及自然杀伤细胞的影响。方法 24例食管癌和24例直肠癌病人,分别随机分为四组,输盐水组(Ⅰ组),输压积红细胞组(Ⅱ组),输全血组(Ⅲ组),输血浆组(Ⅳ组),每组 12例,分别于术前、术后第 1、5、10、15 天测定外周血T淋巴细胞亚群(CD3+、CD4+、CD8+),(CD3++CD4+)/(CD3++CD8+)比值及自然杀伤细胞(CD16+56+)的变化。结果 与术前相比,术后第1天四组病人CD3+、CD4+、CD8+、(CD3++CD4+)/(CD3++CD8+)、CD16+56+显著降低(P<0.05或 0.01);术后第 5天输全血组和输血浆组CD3+、CD4+、CD8+、CD16+56+显著降低(P<0.05),输盐水组及输压积红细胞组各项指标均无显著变化(P>0.05);术后第10天输全血组和输血浆组,CD16+56+仍较低(P<0.05)。组间比较:术后第1天输全血组和输血浆组CD16+56+显著低于输盐水组(P<0.05);术后第 5天输血浆组 CD4+显著低于输压积红细胞组(P<0.05)。结论食管癌和直肠癌病人术后可出现一个可逆性细胞免疫功? Objective It has been shown that perioperative allogenic blood transfusion inhibits immunofunction of cancer patients and may lead to recurrence of cancer and increase in infection rate, but blood transfusion is often inevitable. The purpose of this study was to evaluate the effects of component blood transfusion on postoperative changes in T-lymphocyte subsets and NK cell in patients with esophagus or rectum cancer.Methods Twenty -four patients with esophagus cancer and twenty-four patients with rectum cancer were randomly assigned to one of the four groups of 12 patients each: group I received only normal saline and Ringer's lactate solution ; group II packed red cells 2-4 units; group M whole blood 400-600 ml and group N plasma 400-600ml. Preoperative Hb of all patients was over llOg/L. Patients with endocrine, immunological, liver or kidney disease and those who had receive radio- or chemotherapy were excluded. No cortical hormone was used during perioperative period, trying to avoid its effec t on immunological function and no patient received allogenic blood transfusion after operation. The patients were premedicated with phenobarbital 0.1 and atropine 0.5mg. Anethesia was induced with fentanyi 0.1-0.2mg, midazolam 0.1-0.2mg ?kg'1 and succinylcholine lOOmg and maintained with isoflurane and intermittent IV boluses of fentanyi and vecuromium. Peripheral venous blood samples were taken before operation and on 1st , 5th, 10th and 15th postoperative day for determination of subsets of T-lymphocyte CD3+, CD4+, CD8+, (CD3+ + CD4+)/(CO3+ + CD8+ ) and natural killer cell (CD16+56+) by flow cytometer. Results 1. As compared with the baseline on 1st postoperative day CD3+ , CD4+, CD8+ , (CD3+ + CD4+ )/(CO3+ +CD8+ ) and CD16+56+ all decreased significantly in the four groups (P<0.05-0.01); on 5th postop day CD3+ ,CD4+ , CD8+ and CD16+56+ decreased significantly in group III and IV(P<0.05); on 10th day CD/stse were still significantly lower than the baseline in group ffl and IV(P<0.05) .2. As compared betw een the grou
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2001年第12期721-723,共3页 Chinese Journal of Anesthesiology
关键词 T淋巴细胞亚群 天然杀伤细胞 血液成份输血 食管肿瘤 直肠肿瘤 T Lymphocytes Killer cell, natural Blood component transfusion Neoplasmas in group I and ll on 5th day cD was significant1y lower in group IV than that in group ll (P< 0.05). Conclusions There is a reversible inhibition of ce1lular immunity
  • 相关文献

参考文献1

二级参考文献2

共引文献17

同被引文献27

  • 1陈根殷,王旭光.急性等容血液稀释用于肝叶切除术的临床研究[J].陕西医学杂志,2004,33(8):706-709. 被引量:6
  • 2Van Sandick JW, Boermeester MA, Gisbertz SS, et al.Lymphocyte subsets and T (h) 1/T (h)2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome [J]. Cancer Immunol Immunother, 2003,52 (10):617-624. 被引量:1
  • 3Cho Y, Miyamoto M, Kato K, et al. CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma [J]. Cancer Res, 2003,63(7):1555-1559. 被引量:1
  • 4Derenzini M. The AgNORs [J]. Micron, 2000,31:117-120. 被引量:1
  • 5Sirri V, Roussel P, Hernandez-Verdun D. The AgNOR proteins: qualitative and quantitative changes during the cell cycle [J]. Micron, 2000,31: 121-126. 被引量:1
  • 6Rodriguez JM, Arias-Diaz J, Figueredo MA, et al.Lymphocyte subpopulations and surgery. The role of postoperative patenteral nutrition [ J ]. Nutr Hosp, 1994,9(5): 324-330. 被引量:1
  • 7Tsutsui S, Morita M, Kuwano H, et al. Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma [J]. J Surg Oncol, 1992,49(3): 176-181. 被引量:1
  • 8Bentdal OH, Froland SS, Bosnes V, et al. Alterations in lymphocyte subsets in blood may predict resectability in carcinoma of cardia or oesophagus [J]. Cancer Lett, 1996,100(1-2): 133-138. 被引量:1
  • 9Tashiro T, Yamamori H, Takagi K, et al. Changes in immune function following surgery for esophageal carcinoma[J]. Nutrition, 1999,15(10) :760-766. 被引量:1
  • 10Heidecke CD, Weighardt H, Feith M, et al. Neoadjuvant treatment of esophageal cancer: immunosuppression following combined radiochemotherapy [J]. Surgery, 2002, 132(3):495-501. 被引量:1

引证文献4

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部